Porphyria cutanea tarda in a chronic hemodialysis patient.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7403918)

Published in South Med J on August 01, 1980

Authors

J K Wilkin, R J Kaplan, S R Acchiardo

Articles by these authors

Rosacea. Pathophysiology and treatment. Arch Dermatol (1994) 2.86

The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol (1980) 1.76

Normal circulating adult human red blood cells contain inactive NOS proteins. J Lab Clin Med (2000) 1.62

A national survey of the use of outpatient commitment. Psychiatr Serv (1995) 1.48

Azelaic acid esters do not depigment pigmented guinea pig skin. Arch Dermatol (1990) 1.37

Liquid and solid potassium chloride: bioavailability and safety. Pharmacotherapy (1985) 1.21

Unilateral dermatomal superficial telangiectasia. Nine new cases and a review of unilateral dermatomal superficial telangiectasia. J Am Acad Dermatol (1983) 1.10

Prostaglandins and nicotinate-provoked increase in cutaneous blood flow. Clin Pharmacol Ther (1985) 1.05

Aspirin blocks nicotinic acid-induced flushing. Clin Pharmacol Ther (1982) 1.03

Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int Suppl (1983) 1.01

Dialysis catheter-induced superior vena cava syndrome and downhill esophageal varices. Clin Nephrol (2007) 0.98

Flushing reactions: consequences and mechanisms. Ann Intern Med (1981) 0.97

Neuropsychological functioning in children with shunted uncomplicated hydrocephalus. Childs Brain (1983) 0.95

Molluscum contagiosum venereum in a women's outpatient clinic: a venereally transmitted disease. Am J Obstet Gynecol (1977) 0.94

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison. Am J Kidney Dis (2001) 0.91

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis (2000) 0.90

Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol (1981) 0.89

Intraoperative intercostal nerve freezing to prevent postthoracotomy pain. Ann Thorac Surg (1974) 0.89

Eczema herpeticum in association with familial benign chronic pemphigus. J Am Acad Dermatol (1993) 0.88

Disseminated histoplasmosis in an immunosuppressed patient. South Med J (1977) 0.88

A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease. Clin Nephrol (2001) 0.88

Nodular colloid degeneration: distinctive histochemical and ultrastructural features. Cutis (1985) 0.87

Diffusion of non-electrolytes in brain tissue. Brain Res (1970) 0.87

Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group. Diabetes Care (1995) 0.86

Rosacea. Int J Dermatol (1983) 0.86

Iododerma occurring during thyroid protection treatment. Cutis (1985) 0.86

Reactive perforating collagenosis of diabetes mellitus and renal failure. Cutis (1983) 0.86

Squaric acid and esters: analysis for contaminants and stability in solvents. J Am Acad Dermatol (1985) 0.86

Pityriasis rosea-like rash from captopril. Arch Dermatol (1982) 0.86

Unilateral dermatomal superficial telangiectasia. Dermatologica (1978) 0.85

The movement of sulfate and thiosulfate into in vivo choroid plexus. J Neurobiol (1971) 0.83

Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme. Clin Sci Mol Med Suppl (1975) 0.83

Failure of drug rash to appear in a previously irradiated site. Arch Dermatol (1981) 0.82

An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells. Free Radic Res (2001) 0.82

Bier's spots reconsidered: a tale of two spots, with speculation on a humerus vein. J Am Acad Dermatol (1986) 0.82

Treatment of leishmaniasis with sodium antimony gluconate: transient ECG findings. South Med J (1978) 0.82

Pustular blastomycosis. Int J Dermatol (1977) 0.81

Neurological complications of infections of head and neck. Otolaryngol Clin North Am (1976) 0.81

A quantitative, non-invasive method for the characterization of flushing reactions. J Invest Dermatol (1982) 0.80

Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate. J Dermatol Surg Oncol (1994) 0.80

Role-effectiveness of the pharmacist in the treatment of hemodialysis patients. Am J Hosp Pharm (1978) 0.80

Vascular abnormalities in lichen aureus. J Am Acad Dermatol (1983) 0.80

Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353. Med Pediatr Oncol (1990) 0.79

Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period. Am J Med Sci (1999) 0.79

Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients. Clin Transplant (1994) 0.79

Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol (1983) 0.78

An unusual case of calcinosis cutis. J Am Acad Dermatol (1983) 0.78

Periodic cutaneous blood flow during postocclusive reactive hyperemia. Am J Physiol (1986) 0.78

Cutaneous reactions to lower aliphatic alcohols before and during disulfiram therapy. Arch Dermatol (1982) 0.77

Spinal epidural abscess in children. Early diagnosis and immediate surgical drainage is essential to forestall paralysis. Clin Pediatr (Phila) (1974) 0.77

Does low protein diet halt the progression of renal insufficiency? Clin Nephrol (1986) 0.77

Brain stem compression in rheumatoid arthritis. JAMA (1976) 0.77

Substrate specificity of human cutaneous alcohol dehydrogenase and erythema provoked by lower aliphatic alcohols. J Invest Dermatol (1987) 0.77

Perilesional heparin injections for necrobiosis lipoidica. J Am Acad Dermatol (1983) 0.76

Quantitative assessment of alcohol-provoked flushing. Arch Dermatol (1986) 0.76

The efficacy of nutrition support in infected patients with chronic renal failure. Pharmacotherapy (1991) 0.76

The pharmacokinetics of trichlormethiazide in hypertensive patients with normal and compromised renal function. Eur J Clin Pharmacol (1981) 0.76

Cutaneous vascular sensitivity to lower aliphatic alcohols and aldehydes in Orientals. Alcohol Clin Exp Res (1985) 0.76

Ethnic contact urticaria to alcohol. Contact Dermatitis (1985) 0.76

Acquired persistent erythematous patch on the neck. Acquired nevus flammeus. Arch Dermatol (1994) 0.76

Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability. J Am Acad Dermatol (1984) 0.75

Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. Arch Dermatol (1978) 0.75

Pruritus in sickle cell disease: response to cholestyramine. J Natl Med Assoc (1977) 0.75

Re: chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (2000) 0.75

Squamous-cell and basal-cell carcinomas in black patients. J Dermatol Surg (1976) 0.75

Use of topical products for maintaining remission in rosacea. Arch Dermatol (1999) 0.75

Potential subversion of pregnancy prevention program in the managed care setting. Arch Dermatol (1997) 0.75

Hypotension during hemodialysis: role for nitric oxide. Am J Med Sci (1997) 0.75

Wrong tests, wrong conclusions. Arch Dermatol (1986) 0.75

Contaminants of dinitrochlorobenzene. J Am Acad Dermatol (1983) 0.75

The movement of 5-5 dimethyl-2,4 oxazolidinedione (DMO) between CSF and plasma. Life Sci II (1970) 0.75

Does monosodium glutamate cause flushing (or merely "glutamania")? J Am Acad Dermatol (1986) 0.75

Cutaneous reactive hyperemia: viscoelasticity determines response. J Invest Dermatol (1987) 0.75

Letter: Treatment of atopic dermatitis with topically applied caffeine. Arch Dermatol (1976) 0.75

Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants. Arch Dermatol (1988) 0.75

Captopril and enalapril. Ann Intern Med (1983) 0.75

Basal cell carcinoma arising at the site of venipuncture. Cutis (1985) 0.75

Sclerosing B-cell lymphoma involving the skin. J Cutan Pathol (1994) 0.75

Effect of the cerebrospinal fluid sink on sucrose-diffusion gradients in brain. Exp Neurol (1971) 0.75

Motives and dinitrochlorobenzene. Arch Dermatol (1986) 0.75

Neurofibromatosis. J Tenn Med Assoc (1984) 0.75

Rosacea. Int J Dermatol (1985) 0.75

Parmesan cheese and vegetable-induced histaminuria in a thermal flusher. Cutis (1994) 0.75

Sparing of the vermilion border in an acrodermatitis enteropathica-like syndrome. Cutis (1983) 0.75

The caffeine withdrawal flush: report of a case of "weekend flushing". Mil Med (1986) 0.75

Effect of the CSF sink on thiocyanate concentration gradient in brain. Am J Physiol (1970) 0.75

Flushing reactions in the cancer chemotherapy patient. The lists are longer but the strategies are the same. Arch Dermatol (1992) 0.75

The axon reflex flare. Cutis (1983) 0.75

Red lunulae revisited: a clinical and histopathologic examination. J Am Acad Dermatol (1989) 0.75

Flushing and rosacea: overview and nursing interventions. Dermatol Nurs (1992) 0.75

Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay. J Am Acad Dermatol (1987) 0.75

Unilateral dermatomal superficial telangiectasia. Arch Dermatol (1984) 0.75

Sternocostoclavicular hyperostosis: rheumatologic, radiologic, and dermatologic characteristics. South Med J (1987) 0.75

Lichen aureus. J Am Acad Dermatol (1985) 0.75

Lichenoid eruption produced by captopril. Cutis (1983) 0.75

Buschke-ollendorff syndrome. Cutis (1983) 0.75

Treatment of atopic dermatitis with topically applied caffeine--a follow-up report. Arch Dermatol (1977) 0.75

Climacteric flushing in a patient with carcinoid tumour. Br J Dermatol (1985) 0.75

Chronic urticaria and intermittent anaphylaxis. Reactions to lophendylate. JAMA (1976) 0.75